Na_v1.7

Na_v1.7 Related Products (45):

By Type:	Pan (8) Selective (14)
By Effects:	Inhibitors (40) Antagonists (5)

Cat. No.	Product Name	Effect	Purity

HY-N6691

Veratridine	Inhibitor	99.96%
Veratridine (3-Veratroylveracevine) is a plant neurotoxin, a voltage-gated sodium channels (VGSCs) agonist. Veratridine inhibits the peak current of Nav1.7, with an IC₅₀ of 18.39 µM. Veratridine regulates sodium ion channels mainly by activating sodium ion channels, preventing channel inactivation and increasing sodium ion flow.

HY-12883

PF 05089771	Inhibitor	99.87%
PF 05089771 is a potent, orally active and selective arylsulfonamide Na_v1.7 inhibitor, with IC₅₀ values of 11 nM, 12 nM, 13 nM, 171 nM and 8 nM for hNa_v1.7, cynNa_v1.7, dogNa_v1.7, ratNa_v1.7, and musNa_v1.7, respectively. PF 05089771 is under the study for pain and diabetic neuropathy.

HY-12811

PF-04856264	Inhibitor	≥99.0%
PF-04856264 is a potent and selective Nav1.7 inhibitor, with IC₅₀s of 28, 131, 19, and 42 nM for human, mouse, cynomolgus monkey and dog Nav1.7, respectively. PF-04856264 has low potency against the rat Nav1.7 channel. PF-04856264 shows analgesic effect.

HY-114237

GDC-0276	Inhibitor	99.95%
GDC-0276 is a potent, selective, reversible and orally active NaV1.7 inhibitor with an IC₅₀ value of 0.4 nM. GDC-0276 is well tolerated and exhibits a good pharmacokinetic profile. GDC-0276 has the potential for the treatment of pain and to address shortcomings of existing pain medications, such as addiction and off-target side effects.

HY-12796A

Raxatrigine hydrochloride	Inhibitor	98.94%
Raxatrigine hydrochloride (GSK-1014802 hydrochloride) is a novel small molecule state-dependent sodium channel blocker; Nav1.7 sodium channel inhibitor.

HY-162609

ST-2560	Inhibitor
ST-2560 is a selective inhibitor of the NaV1.7 sodium channel with IC₅₀ value of 39 nM. ST-2560 can be used to study pain behavior and cardiovascular models.

HY-131182

DS-1971a	Inhibitor	99.61%
DS-1971a is a potent, selective, and orally active NaV1.7 inhibitor, with IC₅₀s of 22.8 and 59.4 nM for hNaV1.7 and mNaV1.7, respectively. DS-1971a exerts analgesic effects.

HY-125079

DSP-2230	Inhibitor	98.33%
DSP-2230 is a selective Nav1.7/Nav1.8 blocker, can be used to improve neuropathic pain.

HY-118952A

PF-06456384 trihydrochloride	Inhibitor	99.77%
PF-06456384 trihydrochloride is a highly potent and selective Na_V1.7 inhibitor with an IC₅₀ of 0.01 nM. PF-06456384 trihydrochloride has the potential for formalin pain model research.

HY-139081

GDC-0310	Inhibitor	99.80%
GDC-0310 is a selective acyl-sulfonamide Na_v1.7 inhibitor, with an IC₅₀ of 0.6 nM for hNa_v1.7.

HY-16723

Funapide	Inhibitor	99.83%
Funapide (TV 45070; XEN402) is a potent inhibitor of the sodium channel Nav1.7, Nav1.8 and other Nav channels expressed in the peripheral nervous system. Fornabil is an orally effective analgesic agent.

HY-107405

TC-N 1752	Inhibitor	99.18%
TC-N 1752 is a potent and orally active inhibitor of Nav1.7, with IC₅₀s of 0.17 μM, 0.3 μM, 0.4 μM, 1.1 μM and 2.2 μM at hNav1.7, hNav1.3, hNav1.4, hNaV1.5 and rNav1.8, respectively. TC-N 1752 also inhibits tetrodotoxin-sensitive sodium channels. TC-N 1752 shows analgesic efficacy in the Formalin model of pain.

HY-13985

Nav1.7 inhibitor	Inhibitor	99.99%
Nav1.7 inhibitor (compound II), a sulfonamide, is a potent Nav1.7 inhibitor. Nav1.7 inhibitor has the potential for a wide range of disorders, particularly pain.

HY-19958

XEN907	Inhibitor	98.23%
XEN907 is a potent and spirooxindole blocker of Na_V1.7, with an IC₅₀ of 3 nM. XEN907 also inhibits CYP3A4 in a recombinant human enzyme assay. XEN907 can be used for the research of pain.

HY-131870

GX-201	Inhibitor	98.89%
GX-201 is a selective Na_V1.7 inhibitor, with an IC₅₀ of <3.2 nM for hNa_V1.7.

HY-100727

AM-2099	Inhibitor	98.06%
AM-2099 is a potent and selective inhibitor of voltage-gated sodium channel Nav1.7 with an IC₅₀ of 0.16 μM for human Nav1.7.

HY-P1220A

Huwentoxin-IV TFA	Inhibitor	98.52%
Huwentoxin-IV TFA is a potent and selective sodium channel blocker, inhibits neuronal Nav1.7, Nav1.2, Nav1.3 and Nav1.4 with IC₅₀s of 26, 150, 338 and 400 nM, respectively. Huwentoxin-IV TFA preferentially blocks peripheral nerve subtype Nav1.7 by binding neurotoxin receptor site 4. Huwentoxin-IV TFA has analgesic effects on animal models of inflammatory and neuropathic pain.

HY-12883A

PF-05198007	Inhibitor	99.77%
PF-05198007 is a potent, orally active and selective arylsulfonamide Na_v1.7 inhibitor. PF-05198007 is a compound with a similar pharmacodynamic profile to PF-05089771.

HY-146069

ABBV-318	Inhibitor	98.97%
ABBV-318 is a potent Nav1.7/ Nav1.8 blocker, with IC₅₀s of 2.8 μM and 3.8 μM for hNav1.7 and hNav1.8, respectively. ABBV-318 can be used for the research of pain.

HY-112279

GNE-131	Inhibitor	98.15%
GNE-131 is a potent and selective inhibitor of human sodium channel NaV1.7, with an IC₅₀ of 3 nM.

Name
Email *

	Sorry, but the email address you supplied was invalid.